Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment

Area of Science:

• Gastroenterology
• Molecular Biology
• Immunology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory gastrointestinal disease with complex etiology.
• UC pathogenesis involves immune dysregulation, genetic factors, and environmental influences like diet and stress.

Purpose of the Study:

• To investigate the role of ribosomal protein L19 (RPL19) mRNA in ulcerative colitis (UC).
• To assess the association between RPL19 mRNA levels and UC disease severity and inflammatory markers.

Main Methods:

• Cross-sectional study of 40 UC patients and 29 healthy controls.
• Quantification of RPL19 mRNA in intestinal mucosa using quantitative PCR.
• Statistical analysis of RPL19 mRNA expression in relation to disease activity and cytokine levels.

Main Results:

• RPL19 mRNA levels were significantly altered in UC patients compared to controls.
• RPL19 mRNA showed an inverse correlation with interleukin-2 (IL-2) and interleukin-4 (IL-4) levels.
• RPL19 mRNA expression correlated positively with clinical disease activity indices.

Conclusions:

• Mucosal RPL19 mRNA expression is significantly elevated in UC patients.
• RPL19 mRNA levels correlate with endoscopic and histological disease severity in UC.
• RPL19 represents a potential biomarker for assessing local disease activity in ulcerative colitis.